This week, Leeaf CEO Olga Chabr Grillova attended the American Society for Reproductive Medicine 2023 Scientific Congress & Expo in New Orleans, US, to explore latest research in reproductive endocrinology and infertility, discover forthcoming technological developments in assisted reproductive treatment, and foster strategic collaborations.
The ASRM Congress brings together professionals, researchers, and experts in reproductive medicine and stands out as a pivotal event in the field, and serves as a platform to present innovative approaches.
"As the IVF market witnesses a surge in demand, innovative technological approaches are rapidly emerging, with companies specialising in artificial intelligence and machine learning within the IVF sector navigating their way into the market. However, there is considerable work ahead to truly and significantly enhance treatment outcomes for individuals grappling with infertility," states Olga.
At the forefront of Leeaf's endeavors is the onboarding of IVF clinics for their ambitious multi-centric prospective research, which delves into the impact of comprehensive, four-dimensional patient data – encompassing medical, lifestyle, environmental, and genetic factors – on the outcomes of ovarian stimulation for IVF. In November, Head of Data Science, Lucie Borovickova, will join Olga in presenting innovative research approaches at the upcoming COGI conference in Vienna, Austria.
"We had the privilege of engaging with partners from across the globe and solidify strategic alliances that promise to propel our ongoing research initiatives to new heights," remarks Olga.
If you share our vision to revolutionize assisted reproduction through data-driven discovery, we invite you to connect with Olga at olga.grillova@leeaf.life and join us on this extraordinary journey.
